Home » FDA Approves Beech Tree Labs’ Influenza IND Application
FDA Approves Beech Tree Labs’ Influenza IND Application
Beech Tree Labs, Inc., announced Thursday that the FDA has approved its
IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections.
GEN
GEN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May